Literature DB >> 9453594

Role of monocytes and bacteria in Staphylococcus epidermidis endocarditis.

M J Bancsi1, M H Veltrop, R M Bertina, J Thompson.   

Abstract

The endocardial vegetation which is formed in the course of bacterial endocarditis (BE) contains tissue factor (TF)-dependent procoagulant activity. Earlier studies showed that monocytes are the main source of TF in the vegetations. The TF activity (TFA) of vegetations isolated from Streptococcus sanguis-infected rabbits depended on the numbers of bacteria as well as monocytes in the vegetation. In this study, we investigated whether for Staphylococcus epidermidis, a frequent pathogen in BE, an effect similar to that found for S. sanguis could be shown. In vitro, S. epidermidis was found to stimulate TFA of fibrin adherent monocytes significantly. This stimulation was maximal at a bacterium-to-monocyte ratio of 7. In vivo, TFA was found to be significantly higher in S. epidermidis-infected than in sterile catheter-induced vegetations. Reduction of vegetational bacterial numbers by teicoplanin treatment lead to a small but significant decrease of TFA. Reduction of monocyte numbers by etoposide did not affect vegetational TFA. Comparison of data for S. epidermidis and S. sanguis revealed that at equivalent bacterial numbers, vegetational TFAs were approximately the same for both microorganisms. Combining the results of the present study with those of a previous study using S. sanguis, we conclude that the main factor determining monocyte-dependent vegetational TFA is the number of vegetation-associated bacteria. The lower TFA found for S. epidermidis-infected than for S. sanguis-infected vegetations can be explained by the significantly lower bacterial numbers in the infected vegetations and consequently a lower stimulation of vegetation-associated monocytes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9453594      PMCID: PMC107926     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Effect of warfarin on the induction and course of experimental Staphylococcus epidermidis endocarditis.

Authors:  L Thörig; J Thompson; F Eulderink
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

2.  Experimental bacterial endocarditis. I. Colonization of a sterile vegetation.

Authors:  D T Durack; P B Beeson
Journal:  Br J Exp Pathol       Date:  1972-02

3.  Effects of monocytopenia and anticoagulation in experimental Streptococcus sanguis endocarditis.

Authors:  L Thörig; J Thompson; F Eulderink; J J Emeis; R Van Furth
Journal:  Br J Exp Pathol       Date:  1980-02

4.  Effect of warfarin on the induction and course of experimental endocarditis.

Authors:  J Thompson; F Eulderink; H Lemkes; R van Furth
Journal:  Infect Immun       Date:  1976-12       Impact factor: 3.441

5.  Tissue factor is a major stimulus for vegetation formation in enterococcal endocarditis in rabbits.

Authors:  T A Drake; G M Rodgers; M A Sande
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

6.  Experimental endocarditis due to Pseudomonas aeruginosa. I. Description of a model.

Authors:  G Archer; F R Fekety
Journal:  J Infect Dis       Date:  1976-07       Impact factor: 5.226

7.  Role of granulocytes in experimental Streptococcus sanguis endocarditis.

Authors:  M J Meddens; J Thompson; F Eulderink; W C Bauer; H Mattie; R van Furth
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

8.  Risk factors for the development of prosthetic valve endocarditis.

Authors:  S B Calderwood; L A Swinski; C M Waternaux; A W Karchmer; M J Buckley
Journal:  Circulation       Date:  1985-07       Impact factor: 29.690

9.  Influence of monocytes and antibiotic treatment on tissue factor activity of endocardial vegetations in rabbits infected with Streptococcus sanguis.

Authors:  M J Bancsi; M H Veltrop; R M Bertina; J Thompson
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

10.  The influence of culture conditions and serum lipids on interleukin-1 production by human monocytes.

Authors:  J W Van der Meer; J S Van de Gevel; V W Van Hinsbergh; P C Leijh
Journal:  J Immunol Methods       Date:  1988-04-06       Impact factor: 2.303

View more
  7 in total

1.  Interleukin-10 regulates the tissue factor activity of monocytes in an in vitro model of bacterial endocarditis.

Authors:  M H Veltrop; J A Langermans; J Thompson; M J Bancsi
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Bacterial species- and strain-dependent induction of tissue factor in human vascular endothelial cells.

Authors:  M H Veltrop; H Beekhuizen; J Thompson
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

3.  New concepts in the pathophysiology of infective endocarditis.

Authors:  Eleonora Widmer; Yok-Ai Que; José M Entenza; Philippe Moreillon
Journal:  Curr Infect Dis Rep       Date:  2006-06       Impact factor: 3.725

4.  Monocytes augment bacterial species- and strain-dependent induction of tissue factor activity in bacterium-infected human vascular endothelial cells.

Authors:  M H Veltrop; J Thompson; H Beekhuizen
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  Role of monocytes in experimental Staphylococcus aureus endocarditis.

Authors:  M H Veltrop; M J Bancsi; R M Bertina; J Thompson
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

6.  Glucosyltransferases of viridans group streptococci modulate interleukin-6 and adhesion molecule expression in endothelial cells and augment monocytic cell adherence.

Authors:  Chiou-Yueh Yeh; Jen-Yang Chen; Jean-San Chia
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

7.  The transcriptional programme of human heart valves reveals the natural history of infective endocarditis.

Authors:  Marie Benoit; Franck Thuny; Yannick Le Priol; Hubert Lepidi; Sonia Bastonero; Jean-Paul Casalta; Frédéric Collart; Christian Capo; Didier Raoult; Jean-Louis Mege
Journal:  PLoS One       Date:  2010-01-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.